BIOMAT Database Logo BIOMAT Database Logo

Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors. 2001

M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
DuPont Pharmaceuticals Company, Experimental Station, E500/4803, PO Box 80500, 19880-0500, Wilmington, DE, USA. mpatel5@prius.jnj.com

A series of 4,4-disubstituted quinolinones was prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The C-3 substituted compound 9h displayed improved antiviral activity against clinically significant single (K103N) and double (K103N/L100I) mutant viruses.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Novel HIV-1 reverse transcriptase inhibitors.
June 2008, Virus research,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
August 2009, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Design and synthesis of novel inhibitors of HIV-1 reverse transcriptase.
June 1995, Journal of medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and biological evaluation of naphthyl phenyl ethers (NPEs) as novel nonnucleoside HIV-1 reverse transcriptase inhibitors.
July 2011, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
January 2011, Journal of medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
[Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
November 2009, Yao xue xue bao = Acta pharmaceutica Sinica,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and evaluation of oligo-1,3-thiazolecarboxamide derivatives as HIV-1 reverse transcriptase inhibitors.
May 2000, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
April 2009, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Synthesis and Anti-HIV-1 Evaluation of Some Novel MC-1220 Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors.
May 2016, Archiv der Pharmazie,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and L T Bacheler, and S Erickson-Viitanen, and J D Rodgers
Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents.
March 2000, Antiviral chemistry & chemotherapy,
Copied contents to your clipboard!